HW
VNDA icon

Hancock Whitney’s Vanda Pharmaceuticals VNDA Stock Holding History

Hancock Whitney’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-13,156
Closed -$282K – 812
2021
Q2 		$282K Sell
13,156
-2,633
-17% -$47.1K 0.01% 696
2021
Q1 		$237K Buy
15,789
+146
+0.9% +$2.36K 0.01% 704
2020
Q4 		$205K Sell
15,643
-5,462
-26% -$65.7K 0.01% 744
2020
Q3 		$203K Buy
+21,105
New +$226K 0.01% 712

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hancock Whitney's VNDA Position: Q3 2021 in Review

Hancock Whitney sold out of Vanda Pharmaceuticals (VNDA) in Q3 2021, closing a stake of 13,156 shares — an estimated $282K sold.

Hancock Whitney first reported a position in VNDA in Q3 2020 and held it in 4 quarters. The position peaked at $282K in Q2 2021. 182 funds tracked by Wall St. Rank hold VNDA as of Q3 2021.

  • Hancock Whitney reported no remaining Vanda Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Hancock Whitney sold 13,156 Vanda Pharmaceuticals shares in Q3 2021, an estimated $282K.
  • Hancock Whitney first reported a position in Vanda Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Hancock Whitney's Vanda Pharmaceuticals position peaked at $282K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.